Ptc Therapeutics (PTCT) Assets Average (2013 - 2026)

Ptc Therapeutics' Assets Average history runs 14 years deep, the most recent figure standing at $2.9 billion for Q1 2026.

• On a quarterly basis, Assets Average rose 32.28% year-over-year to $2.9 billion in Q1 2026; TTM through Mar 2026 was $2.9 billion, a 32.28% increase from a year earlier, with the FY2025 full-year figure at $2.3 billion, up 27.86% from the prior year.
• Assets Average improved to $2.9 billion in Q1 2026 per PTCT's latest filing, from $2.8 billion in the prior quarter.
• Across five years, Assets Average topped out at $2.9 billion in Q1 2026 and bottomed at $1.3 billion in Q3 2023.
• The 5-year median for Assets Average is $1.8 billion (2024), against an average of $2.0 billion.
• Across the five-year window, Assets Average slipped 23.15% in 2023 and soared 56.25% in 2025, its largest moves.
• Year by year, Assets Average stood at $1.6 billion in 2022, then retreated by 3.85% to $1.6 billion in 2023, then rose by 12.41% to $1.8 billion in 2024, then surged by 56.25% to $2.8 billion in 2025, then gained by 4.07% to $2.9 billion in 2026.
• Per Business Quant, the three latest PTCT Assets Average figures stand at $2.9 billion (Q1 2026), $2.8 billion (Q4 2025), and $2.6 billion (Q3 2025).